Validation of a Nutrition Screening Tool
- Conditions
- Adenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial CancerEsophageal CancerFallopian Tube CancerGastric CancerOvarian CancerSarcomaVaginal CancerVulvar Cancer
- Registration Number
- NCT01851928
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Brief Summary
The objective of this study is to evaluate the sensitivity and specificity of two nutrition screening tools to identify inpatients with malnutrition or at risk of malnutrition. The two tools are the Royal Marsden Abridged Adult Nutrition Screening Tool (AANST) and the Malnutrition Screening Tool (MST)\[10\] The tools will be compared with the currently accepted gold standard, Patient Generated Subjective Global Assessment (PG-SGA). Both screening tools are in the form of scored questionnaires and are suitable for electronic input.
The ultimate objective is to select an adult inpatient nutrition screening tool with the highest sensitivity for future use in the oncology inpatient setting in order to allow prompt commencement of an appropriate nutrition care plan.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 128
- All adult inpatients, over the age of 18, admitted to RMH for whom a measured weight and height can be obtained
Exclusion Criteria
- Patients for whom it is not possible to obtain a measured height and weight
- People with a definitive diagnosis of dementia
- People who lack capacity to understand the purpose of the study and to consent
- Patients who are unable to understand and speak English
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity of Screening Tool 24 hrs The primary endpoint of the study is the sensitivity of each screening tool as compared to the gold standard of PG-SGA when completed by a trained dietitian.
- Secondary Outcome Measures
Name Time Method Specificity of the Tool 24 hrs Secondary endpoints are as follows:
* specificity of the screening tool
* proportion of inpatients with malnutrition on admission
Trial Locations
- Locations (1)
Royal Marsden Hospital NHS Foundation Trust
🇬🇧London, London .., United Kingdom